Related references
Note: Only part of the references are listed.Extracellular Vesicles in Oncology: Progress and Pitfalls in the Methods of Isolation and Analysis
Donatella Lucchetti et al.
BIOTECHNOLOGY JOURNAL (2019)
Extracellular Vesicles in Oncology: Progress and Pitfalls in the Methods of Isolation and Analysis
Donatella Lucchetti et al.
BIOTECHNOLOGY JOURNAL (2019)
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC
Mei-Mei Zheng et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The circulating transcriptome as a source of cancer liquid biopsy biomarkers
Carla Sole et al.
SEMINARS IN CANCER BIOLOGY (2019)
Biological background of the genomic variations of cf-DNA in healthy individuals
J. Liu et al.
ANNALS OF ONCOLOGY (2019)
Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
Hannah K. Brown et al.
DRUG DISCOVERY TODAY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles
Klaus G. Griewank et al.
MODERN PATHOLOGY (2018)
Estrogen receptor (ESR1) mutation in bone metastases from breast cancer
Stephan Bartels et al.
MODERN PATHOLOGY (2018)
The value of cell-free DNA for molecular pathology
Caitlin M. Stewart et al.
JOURNAL OF PATHOLOGY (2018)
Machine learning to detect signatures of disease in liquid biopsies - a user's guide
Jina Ko et al.
LAB ON A CHIP (2018)
Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests
Gonzalo Torga et al.
JAMA ONCOLOGY (2018)
Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays Reply
Gonzalo Torga et al.
JAMA ONCOLOGY (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Proteomic profiling of the cancer cell secretome: informing clinical research
Yung-Chin Hsiao et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Circulating tumor cells: clinical validity and utility
Luc Cabel et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection
Stephan Bartels et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial
Jana Fassunke et al.
VIRCHOWS ARCHIV (2017)
Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers
Bob T. Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Application of Digital PCR in Detecting Human Diseases Associated Gene Mutation
Yu Tong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
Biagio Ricciuti et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
R. Jonas A. Nilsson et al.
ONCOTARGET (2016)
Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
Felix Leung et al.
CLINICAL CHEMISTRY (2016)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Lambert Busque et al.
NATURE GENETICS (2012)
Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
EP Diamandis
MOLECULAR & CELLULAR PROTEOMICS (2004)
Cancer diagnosis using proteomic patterns
TP Conrods et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2003)
Share Paper
